Design, Synthesis and Anticancer Biological Evaluation of Novel 1,4-Diaryl-1,2,3-triazole Retinoid Analogues of Tamibarotene (AM80)

AUTOR(ES)

Aleixo, Mariana A. A., Garcia, Taís M., Carvalho, Diego B., Viana, Luiz H., Amaral, Marcos S., Kassab, Najla M., Cunha, Marilin C., Pereira, Indiara C., Guerrero Jr., Palimécio G., Perdomo, Renata T., Matos, Maria F. C., Baroni, Adriano C. M.

FONTE

J. Braz. Chem. Soc.

DATA DE PUBLICAÇÃO

2018-01

RESUMO

We report herein the design and synthesis via click chemistry of twelve novel triazole retinoid analogues of tamibarotene (AM80) and the evaluation of their anticancer activities against six cancer cell lines: HL60, K562, 786, HT29, MCF7 and PC3. Among the synthesized compounds, two were more potent than tamibarotene against solid tumor cells, and one of them had similar potency to tamibarotene against HL60 cells. The bioisosteric exchange between the amide group and the 1,2,3-triazole core in the retinoid agent tamibarotene (AM80) reported in this work is a valid strategy for the generation of useful compounds against cancer.

Documentos Relacionados

• Synthesis and Antitrypanosomastid Activity of 1,4-Diaryl-1,2,3-triazole Analogues of Neolignans Veraguensin, Grandisin and Machilin G
• Synthesis and evaluation of 1-alkyl-4-phenyl-[1,2,3]-triazole derivatives as antimycobacterial agent
• Synthesis of 1,2,3-Triazole Derivatives of 4,4'-Dihydroxybenzophenone and Evaluation of Their Elastase Inhibitory Activity
• Synthesis and phytotoxic activity of 1,2,3-triazole derivatives
• Synthesis and Evaluation of Antibacterial Activity of 1,2,3-Triazole and Ether Derivatives of Paeonol